Inovio Pharmaceuticals's total assets for Q3 2025 were $69.39M, an increase of 1.68% from the previous quarter. INO total liabilities were $77.11M for the fiscal quarter, a 94.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.